National and Kapodistrian University of Athens
Ενδοθηλίνη αίματος σε άτομα με σύνδρομο Turner - συσχέτιση με δείκτες αθηρωμάτωσης
Abstract
dc:descriptionTurner syndrome (TS) is one of the most common chromosomal disorders in humans and is due to sex chromosomes anomalies. Most of the patients with TS have one X chromosome (45X0) in all their cells, while others present mosaicism or structural abnormalities of the X chromosomes. TS is associated with a high incidence of cardiovascular disorders, such as coronary heart disease, arteriosclerosis and hypertension. Women with TS have a threefold increase in mortality, primarily as a result of their cardiovascular complications. Endothelin-1 is a 21-aminoacid peptide, which is mainly produced by the vascular endothelial cells. It is considered the most potent endogenous vasoconstrictor and has a strong mitogenic action on the vascular smooth muscle cells. Endothelin plays a significant role in the pathogenesis of many cardiovascular diseases, such as hypertension, coronary heart disease, arteriosclerosis and heart failure. Plasma endothelin concentrations are correlated with the severity of some of these disorders and it has been suggested that endothelin values can be used as prognostic or diagnostic indices. In the present study we examined the plasma endothelin values in preadolescents, adolescents and young adults with T.S, and in normal females of comparable ages and stages of puberty, in an effort to determine possible alterations with estrogens endogenous or exogenous, as well as correlations with arteriosclerosis risk factors. Blood lipids and blood pressure (A.P) were also measured and correlated with endothelin values. The study group consisted of 82 individuals, 40 TS patients (aged 3,75-24,25 years, mean 14,5± 4,789) and 42 healthy girls, (aged 3-24,5 years, mean 11,63±4,97). The following determinations were carried out: cholesterol, LDL, HDL, triglycerides, SGOT, SGPT, γ-GT by the usual laboratory techniques. Plasma endothelin was determined by radioimmunoassay (Nichols Institute Diagnostics Endothelin 125/RIA). The clinical parameters recorded were: height, weight, blood pressure and staging of puberty using Tanner’s criteria. TS patients and controls were divided into groups according to the stage of puberty (Tanner I to V), since this staging would reflect the impact of endogenous or exogenous estrogens, in the individuals studied. For the statistical evaluation of the results, the Pearson correlation coefficient was used to assess the relationship between the variables and the ANCOVA paradigm was employed with Control/Turner and Tanner I+II and Tanner IV+V as the independent and endothelin, systolic blood pressure (SBP), diastolic blood pressure (DBP), cholesterol, HDL, LDL, triglycerides, as the dependent variables. Since the groups in the study differed significantly in respect to age and since age highly correlated with certain dependent variables, it was used as a covariate (the ANCOVA model), in order to statistically control for this difference. All analyses were carried out using the STATISTICA 6.0 software package by StatSoft Inc. The value of endothelin-1 (p=0,005), SBP (p=0,000), DBP (p=0,000), cholesterol (p = 0,000), LDL (p = 0,000), HDL (p=0,000) and triglycerides (p=0,000) were higher in TS patients in comparison to the controls. Evaluating these parameters in the different stages of puberty (Tanner I to V), we found that endothelin concentrations were higher in TS Tanner I group than in comparison to the control Tanner I group (p=0,038), lower in TS Tanner V group than in both TS- Tanner I (p=0,033) and TS-Tanner II (p=0.045) groups, while there was no statistical difference in endothelin concentration between TS Tanner V group and control-Tanner V group. We also found that both SBP and DBP were higher in TS Tanner I group compared to control Tanner I group (p=0,000 and p=0,000 respectively). In order to have higher number of subjects for comparison we grouped subjects with pubertal stages Tanner I and II and Tanner IV and V in both TS and controls. Evaluating the parameters in the new groups, we found that endothelin concentrations were higher in TS-Tanner I/II group versus control- Tanner I/II group (p=0,001), and in TS-Tanner I/II group versus TS-Tanner IV/V group (p=0,000) while they were comparable in TS-Tanner IV/V and control- Tanner IV/V group (p=0,999). SBP and DBP were higher in TS-Tanner I/II group versus control-Tanner I/II group (p=0,000 and p = 0,000, respectively). Cholesterol levels were higher in TS Tanner I/II group versus control Tanner I/II group (p=0,000) and in TS Tanner IV/V group versus control-Tanner IV/V group (p=0,002). LDL levels were higher in TS Tanner I/II group versus control Tanner I/II group (p=0,000) and in TS Tanner IV/V group versus control Tanner IV/V group(p = 0,002). Endothelin was positively correlated with SBP in the whole group (r=0,4128, p=0,000), as well as in the control group (r=0,4496, p=0,003) and the TS group (r=0,3289, p=0,038). When considered separately in the different pubertal stages endothelin was positively correlated with cholesterol in the whole group (r=0,2476, p=0,025) and in the TS-Tanner I/II group (r=0,5033, p=0,02) and also was positively correlated with LDL in the whole group (r=0,281, p=0,011) and in the TS-Tanner I/II group (r=0,5198, p=0,016). Finally endothelin was negatively correlated with age only in TS group (r=0,3788, p=0,016). In conclusion, our data showed that all cardiovascular risk factors (blood pressure, cholesterol, HDL, LDL, triglycerides) were higher in TS patients compared with the control group. In addition, endothelin plasma concentrations were higher in TS patients versus the control group. After evaluating endothelin plasma concentrations in the different stages of puberty (which reflect the impact of endogenous and exogenous estrogens), we concluded that hormone replacement therapy (HRT) with estrogens, results in the normalization of plasma endothelin concentrations in TS patients. Thus, the cardioprotective action of estrogens in TS patients may, at least in part, be attributed to the normalization of endothelin concentrations, resulting in the reduction of endothelin’s vasoconstrictive and mitogenic actions in the vascular smooth muscle cells. Furthermore, the positive correlation between endothelin and systolic blood pressure, suggested the significant role of endothelin in the pathogenesis of hypertension and endothelium cardiovascular disease in general. The finding, that hormone replacement therapy with estrogens, results in the normalization of plasma endothelin concentrations in TS patients, combined with the fact that these patients have a higher prevalence of cardiovascular disorders, despite the fact that they receive HRT, can have the following interpretation: 1) other factors besides endothelin (hyperlipidemia), are responsible for the higher prevalence of cardiovascular disease in T.S. 2) the cardiovascular damage caused by the elevated concentrations of endothelin, in the long pre-adolescent period of TS patients is irreversible, having in mind that the arteriosclerosis of the adults is thought to have it’s roots in childhood or even earlier. Based on the above data we can risk the hypothesis, that in order to protect the cardiovascular system of TS patients, very small doses of estrogens must be administrated during preadolescent period, in order to achieve estrogens levels similar to the levels found in healthy children. It is obvious, that for such an intervention a long prospective study is required.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Καρλαύτης, Ηλίας
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19958